Last Updated:
Name Designation Appointment Date Status
Kusum Sharma

Appointed as Director since June 2014

Director 09-Jun-2014 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Hari Om Sharma

Appointed as Director since March 2011

Director 01-Mar-2011 Current

People Timeline

Explore the timeline of key personnel in Chemsynth Drugs & Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address T-2, 3Rd Floor, Savitri Plaza-1, Plot No.- 5,Lsc-2 I.P. Extension, Patparganj, New Delhi Delhi, 110092, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110092
  • Country India
  • Website cdppl.com
Frequently Asked Questions
How can I contact Chemsynth Drugs & Pharmaceuticals Private Limited?
You can contact Chemsynth Drugs & Pharmaceuticals Private Limited through their registered address at T-2, 3Rd Floor, Savitri Plaza-1, Plot No.- 5,Lsc-2 I.P. Extension, Patparganj, New Delhi Delhi, 110092, India, or via their website at cdppl.com. Social media links are also provided where applicable.
Who are the current directors of Chemsynth Drugs & Pharmaceuticals Private Limited?
The current directors of Chemsynth Drugs & Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • KUSUM SHARMA
  • HARI OM SHARMA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available